Skip to main content

Want a detailed portfolio tracker?

Performance analysis of LAVA Therapeutics (LVTX)

Annual Return

Over the past 3 years, LVTX has had an average annual return of -14.81%, underperforming the benchmark SPY, which returned +22.40% annual.

Over the past 5 years, LVTX has had an average annual return of -33.61%, underperforming the benchmark SPY, which returned +12.95% annual.

Since Mar 25, 2021, LVTX has had an average annual return of -36.11%, underperforming the benchmark SPY, which returned +14.29% annual.

20252024202320222021
+83.01%-39.82%-54.86%-36.35%-61.54%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025+3.01%+31.68%-1.55%-1.58%+4.81%+0.76%+15.17%+3.29%-0.64%+4.12%+7.13%+0%+83.01%
2024+5.70%+99.40%-0%-13.22%-21.82%-20.32%+18.90%-18.24%-5.15%+9.04%-11.61%-40.57%-39.82%
2023+3.96%-38.47%-25.86%-9.04%+25.85%+6.85%-7.39%-5.86%-16.96%-19.07%+27.40%+4.25%-54.86%
2022+0.36%-17.02%-3.93%-7.51%-26.28%-1.67%-11.88%-1.93%+79.25%-5.26%+27.25%-36.47%-36.35%
2021+6.22%-21.65%-4.63%-4.15%-49.17%+18.44%-9.61%+28.72%-8.93%-20.75%-61.54%

Drawdown analysis of LAVA Therapeutics (LVTX)

The maximum drawdown for the LVTX was -94.33%, occurring on Feb 11, 2025. This drawdown has not yet recovered.

The current LVTX drawdown is -89.12%.

Since Mar 25, 2021 LVTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-94.33%Apr 13, 2021963Feb 11, 2025OngoingOngoingOngoing
-14.41%Mar 31, 20211Apr 1, 20212Apr 6, 20213
-12.59%Mar 25, 20211Mar 26, 20213Mar 31, 20214
-4.88%Apr 6, 20211Apr 7, 20214Apr 13, 20215